Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries

Am J Physiol Cell Physiol. 2011 Aug;301(2):C441-50. doi: 10.1152/ajpcell.00029.2011. Epub 2011 Apr 27.

Abstract

Chronic hypoxia (CH) activates the Ca(2+)-dependent transcription factor nuclear factor of activated T cells isoform c3 (NFATc3) in mouse pulmonary arteries. However, the mechanism of this response has not been explored. Since we have demonstrated that NFATc3 is required for CH-induced pulmonary arterial remodeling, establishing how CH activates NFATc3 is physiologically significant. The goal of this study was to test the hypothesis that endothelin-1 (ET-1) contributes to CH-induced NFATc3 activation. We propose that this mechanism requires increased pulmonary arterial smooth muscle cell (PASMC) intracellular Ca(2+) concentration ([Ca(2+)](i)) and stimulation of RhoA/Rho kinase (ROK), leading to calcineurin activation and actin cytoskeleton polymerization, respectively. We found that: 1) CH increases pulmonary arterial pre-pro-ET-1 mRNA expression and lung RhoA activity; 2) inhibition of ET receptors, calcineurin, L-type Ca(2+) channels, and ROK blunts CH-induced NFATc3 activation in isolated intrapulmonary arteries from NFAT-luciferase reporter mice; and 3) both ET-1-induced NFATc3 activation in isolated mouse pulmonary arteries ex vivo and ET-1-induced NFATc3-green fluorescence protein nuclear import in human PASMC depend on ROK and actin polymerization. This study suggests that CH increases ET-1 expression, thereby elevating PASMC [Ca(2+)](i) and RhoA/ROK activity. As previously demonstrated, elevated [Ca(2+)](i) is required to activate calcineurin, which dephosphorylates NFATc3, allowing its nuclear import. Here, we demonstrate that ROK increases actin polymerization, thus providing structural support for NFATc3 nuclear transport.

Publication types

  • Research Support, American Recovery and Reinvestment Act
  • Research Support, N.I.H., Extramural

MeSH terms

  • Actins / metabolism
  • Active Transport, Cell Nucleus
  • Animals
  • Calcineurin / metabolism
  • Calcineurin Inhibitors
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling
  • Cells, Cultured
  • Chronic Disease
  • Cytoskeleton / metabolism
  • Disease Models, Animal
  • Endothelin Receptor Antagonists
  • Endothelin-1 / antagonists & inhibitors
  • Endothelin-1 / genetics
  • Endothelin-1 / metabolism*
  • Genes, Reporter
  • Humans
  • Hypoxia / genetics
  • Hypoxia / metabolism*
  • Male
  • Membrane Transport Modulators / pharmacology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism*
  • NFATC Transcription Factors / genetics
  • NFATC Transcription Factors / metabolism*
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / metabolism*
  • RNA, Messenger / metabolism
  • Receptors, Endothelin / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Time Factors
  • Transcriptional Activation
  • Transfection
  • Up-Regulation
  • rho GTP-Binding Proteins / metabolism
  • rho-Associated Kinases / antagonists & inhibitors
  • rho-Associated Kinases / metabolism
  • rhoA GTP-Binding Protein

Substances

  • Actins
  • Calcineurin Inhibitors
  • Calcium Channels, L-Type
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Membrane Transport Modulators
  • NFATC Transcription Factors
  • Nfatc3 protein, mouse
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • Receptors, Endothelin
  • Recombinant Fusion Proteins
  • rho-Associated Kinases
  • Calcineurin
  • RhoA protein, mouse
  • rho GTP-Binding Proteins
  • rhoA GTP-Binding Protein